StonvexLoading…
StonvexStonvexStonvexCore line items from CB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $14.77B | $59.40B | $44.34B | $28.19B |
Operating Income | $2.99B | $13.04B | $9.27B | $5.38B |
Net Income | $2.32B | $10.31B | $7.10B | $4.30B |
EPS (Diluted) | $5.88 | $25.68 | $17.61 | $10.63 |
Total Assets | $275.46B | $272.33B | $270.21B | $261.56B |
Total Liabilities | $195.54B | $192.55B | $192.40B | $187.12B |
Cash & Equivalents | $2.63B | $2.47B | $2.45B | $2.37B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 388.50M | 391.10M | 394.32M | 398.66M |